. The titres of 34 patients with cystic fibrosis, from whom P aeruginosa was never isolated during the next three years, ranged from <105 to <216, mean 127 (6-0).
Forty nine patients with cystic fibrosis who had chronic P aeruginosa all had very high serum IgA titres (between 1200 and 16 300), which were significantly greater than control titres (p<0-001).
There was a wide range of titres in patients with cystic fibrosis with intermittent P aeruginosa: 51/57 patients had titres that were greater than the control range, between 275 and 6650. There were two patients in whom IgA titres remained within the control range throughout the study period, despite intermittent isolations of P aeruginosa and increases in IgG titre. No difference in the rate of change of lung function or chest radiography could be detected between these two patients and patients who had increased IgA and IgG titres. Four patients with intermittent P aeruginosa: isolations had titres between 105 and 235, which were within the control range. These four patients are considered in more detail in Figure 2 Serum IgA antibody titre to P aeruginosa in 26 patients with cystic fibrosis before and after the first isolation from the respiratory tract. The arrows indicate the time ofthe beginning ofintermittent isolations ofP aeruginosa. The upper limit ofcontrols is the statistical limit of99 9% plus 100/% interassay error. *Treatment was two weeks of an intravenous aminoglycoside (for example, tobramycin, amikacin) and a ureidopenicil tin (for example, aziocillin, piperacilin).
tThe time after treatment when P aeruginosa was reisolated from the patient. There were, however, two patients (one with intermittent and one with more than five years of chronic P aeruginosa) who stood out as being different. They both had a significantly higher ratio of IgA:IgG titres than the other patients in the corresponding group (p<OOOl), which was maintained over a period of several years. This was due to a very pronounced IgA response and a very low IgG response. Both patients had much higher Shwachman scores and lower Chrispin-Norman scores than the other patients in the same group.
Discussion
All patients with cystic fibrosis with chronic pseudomonal infection had a very pronounced IgA response. Patients with intermittent P aeruginosa also had titres greater than the control range, with the exception of six patients. Two of these six patients had no detectable increase in serum IgA titre throughout periods of [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] months of repeated P aeruginosa isolations and increased IgG titres, which are indicative of infection.'2 13 There was no difference in clinical variables between these two patients and patients who had increased IgA titres. Consistent changes in clinical variables, however, are detectable only in patients with chronic pseudomonal infection,2 so these two patients may need to be studied for a longer time before any conclusions can be drawn on the effect of a lack of specific serum IgA antibodies on their prognosis. Furthermore, a lack of IgA antibodies in serum should be interpreted with caution in the absence of data on concentrations in sputum: a dissociation between local and systemic concentrations of precipitins against P aeruginosa and Staphylococcus aureus has been reported for some antigens in a small number of patients with chronic infection. '4 In contrast, four patients had no detectable increase in both IgA and IgG titres during periods of up to 17 months before and after one to three isolations of P aeruginosa. Serum concentrations of IgA and IgG remained within the normal range throughout the study period. It is unlikely that antibodies to P aeruginosa were present in serum but not detected: the outer membrane proteins of P aeruginosa are highly conserved,' and the serotypes of isolates from these patients were included in the assay. The results presented here show that the vast majority (90%) of patients with cystic fibrosis produce specific IgA antibodies before the organism is present in sufficient numbers to be isolated from the respiratory tract (104-105 colony forming units/ml in our laboratory) but this does not prevent pseudomonal infection becoming established and eventually overwhelming. It is possible that although the serum titre is increased, the sputum concentration is not increased or is insufficient to cope with the bacterial load. A defect in the assembly of sIgA has been reported,'6 which would render it more susceptible to cleavage by proteases produced by P aeruginosa. Another possibility is that, although the IgA concentration in the lungs is adequate, there are defects in nonspecific components, such as ciliary movement or phagocytosis, so that removal of organisms from the respiratory tract could be suboptimal.
The presence of serum IgA antibodies, which have been shown to be specific for P aeruginosa,8 at higher concentrations than normal would seem to indicate the presence of the organisms in the respiratory tract. It could be argued that increased serum IgA antibodies in the absence of serum IgG antibodies signifies harmless colonisation, rather than tissue invasion and infection. What is perhaps of greatest importance to the patient is treatment at a stage when the course of infection can be radically altered.
We have shown previously that treatment at an early stage of infection apparently eradicated pseudomonal infection (as judged by bacteriology and serum IgG titres) in six of 16 patients.12 After intervals of five to 32 months, P aeruginosa again began to be isolated from five of these six patients. It appears that IgA measurement may be better than IgG measurement at predicting the recurrence of pseudomonal infection: an increase in IgA titres was detected in all five patients before the organism reappeared, whereas an increase in IgG titre was only detected in one patient. This was an unexpected finding; the cause and its significance are unclear, but should be clarified.
Because both IgA and IgG are involved in the immune response to P aeruginosa we considered the association between them. The ratio of IgA:IgG titres decreased in individual patients with increasing time of infection, so patients with intermittent P aeruginosa had a significantly higher ratio of IgA:IgG titres than patients with chronic P aeruginosa. There was some overlap between the two groups, presumably due to the arbitrary division between them. There were two patients (one with intermittent and one with chronic P aeruginosa) who stood out as being totally anomalous. They both had ratios that were significantly higher than other patients in the same group, maintained over study periods of two to three years. These two patients both showed a lack of clinical deterioration: their clinical state and chest radiograph were dramatically better than those of the other patients in the corresponding group. Both these patients had a very pronounced IgA response and an IgG response that was very low or absent. A high ratio of IgA:IgG could be caused in two ways, both of which suggest a less damaging infection. A high ratio could be indicative of an IgA response which is sufficient to prevent tissue invasion and so there is no stimulus to induce IgG production. Alternatively, it is possible that, as IgA antibodies predominate in the upper airways while IgG antibodies predominate in the lower respiratory tract,5 a high ratio could indicate an infection predominantly in the upper airways while a low ratio suggests infection deeper in the lungs.
In conclusion, the serum IgA response to P aeruginosa seems to follow a similar pattern to that of serum IgG antibodies: titres were very low in patients with no history of pseudomonal infection, high in patients with intermittent P aeruginosa, and very high in patients with chronic P aeruginosa. Measurement of IgA titres has confirmed that P aeruginosa isolates were transient and non-pathogenic in a small proportion of patients. Comparison of the IgA and IgG titres identifies those patients with a very good prognosis after the onset of pseudomonal infection. These results suggest that IgA measurement could improve still further patient management in two situations. First, by predicting the reappearance of P aeruginosa after apparent eradication and secondly, in some patients, by giving an even earlier indication than IgG measurement of the presence of the organism in the respiratory tract in the very earliest stages of infection.
